KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Total Non-Current Liabilities (2020 - 2025)

Historic Total Non-Current Liabilities for Oscar Health (OSCR) over the last 6 years, with Q4 2025 value amounting to $5.3 billion.

  • Oscar Health's Total Non-Current Liabilities rose 4065.85% to $5.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 billion, marking a year-over-year increase of 4065.85%. This contributed to the annual value of $5.3 billion for FY2025, which is 4065.85% up from last year.
  • Oscar Health's Total Non-Current Liabilities amounted to $5.3 billion in Q4 2025, which was up 4065.85% from $4.7 billion recorded in Q3 2025.
  • In the past 5 years, Oscar Health's Total Non-Current Liabilities registered a high of $5.3 billion during Q4 2025, and its lowest value of $1.6 billion during Q3 2021.
  • In the last 5 years, Oscar Health's Total Non-Current Liabilities had a median value of $3.4 billion in 2022 and averaged $3.3 billion.
  • Per our database at Business Quant, Oscar Health's Total Non-Current Liabilities skyrocketed by 9486.68% in 2022 and then crashed by 2510.48% in 2023.
  • Over the past 5 years, Oscar Health's Total Non-Current Liabilities (Quarter) stood at $1.9 billion in 2021, then surged by 92.3% to $3.6 billion in 2022, then dropped by 23.42% to $2.7 billion in 2023, then surged by 37.94% to $3.8 billion in 2024, then skyrocketed by 40.66% to $5.3 billion in 2025.
  • Its last three reported values are $5.3 billion in Q4 2025, $4.7 billion for Q3 2025, and $5.2 billion during Q2 2025.